Youper Wellbeing AI Chatbot
AI-powered conversational chatbot for mood tracking, emotional wellbeing reflection, and thought journaling
Company profile
Company profile
Youper is an AI-powered mental health and wellbeing application based in San Francisco that uses conversational artificial intelligence to support emotional health. The platform enables users to track their mood, engage in reflective conversations about their emotional state, and maintain a digital journal of their thoughts and feelings. Youper is designed with safety as a core principle, implementing comprehensive safeguards to prevent harmful interactions, including detection systems for suicidal ideation and self-harm expressions, automatic crisis referrals to services like the 988 Suicide & Crisis Lifeline, and content filters to prevent the generation of harmful responses. The application is transparent about its AI-powered nature, clearly disclosing that users interact with an AI system rather than human therapists. Youper explicitly states it does not provide medical advice, diagnosis, or treatment, and is not a substitute for professional mental health care. The platform has not received FDA clearance or approval as a medical device. Youper is intended exclusively for users aged 18 and older and is not designed for minors. The company emphasizes that while its AI detection systems are sophisticated, they are not infallible, and users experiencing mental health crises should contact professional emergency services immediately.
Company description Youper official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered conversational chatbot for mood tracking, emotional wellbeing reflection, and thought journaling
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of affective disorders · Dec 1, 2025
Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study.Journal of medical Internet research · Jun 22, 2021
Impact of the COVID-19 Pandemic on Mental Health among 157,213 Americans.Journal of affective disorders · May 1, 2021
Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial.Alcoholism, clinical and experimental research · Dec 1, 2019
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Youper's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.